MedPath

Apelin Levels and G212A Polymorphism of Apelin Receptor (APJ)

Completed
Conditions
Diabetes Mellitus Type 2
Obesity
Insulin Resistance
Registration Number
NCT01121172
Lead Sponsor
Aristotle University Of Thessaloniki
Brief Summary

The aim of this study is to investigate serum apelin levels as well as their possible association with G212A polymorphism of the apelin receptor in obese children and adolescents.

So far apelin has been reported to be involved in the pathophysiology of various heart diseases such as cardiomyopathies and heart failure. According to recent reports in adults apelin seems to be associated with impaired glucose metabolism, particularly in newly diagnosed diabetes type 2 patients. Obesity is associated with insulin resistance and compensatory hyperinsulinemia leading to diabetes mellitus type 2 even in youngsters. The researchers will try to investigate the role of this new adipokine in order to early detect and to prevent similar entities in childhood obesity.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
180
Inclusion Criteria
  • Obese children and adolescents (aged 2-16 years old)
Exclusion Criteria
  • Chronic diseases
  • Hypothyroidism
  • Medication

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum Apelin LevelsFirst day after enrollment and after 8-hours of night fasting, at approximately 8:00 pm in the morning

Apelin levels were measured in serum of participants, in fasting state

Secondary Outcome Measures
NameTimeMethod
Frequency of G212A Polymorphism of Apelin Receptor in Obese Children and AdolescentsFirst day after enrollment

Number of participants with Apelin Receptor Gene G212A polymorphism by genotype group

Trial Locations

Locations (1)

Unit of Pediatric Endocrinology, Diabetes and Metabolism-4th Department of Pediatrics, Medical School of Aristotle University of Thessaloniki

🇬🇷

Thessaloniki, Greece

© Copyright 2025. All Rights Reserved by MedPath